Intraluminal Vesicles as Transfection Intermediaries

<b>Background:</b> To address hepatotropic body distribution and toxicity, transfection systems based on protein architecture have been proposed. Attenuated anthrax toxin (aATx) has provided the backbone for a first in class transfection system that, in the wild, uses intraluminal vesicles (ILVs) as an intermediary compartment during the translocation of large molecules into the cytosol. Small interfering (si)RNA molecules non-covalently attached to a carrier (LFn-PKR) would not be predicted to be an aATx translocase (protective antigen (PA)) substrate. Previously, siRNA has been shown to be delivered to the cytosol using this system. <b>Methods:</b> Here, the localisation of <sup>32</sup>P-labelled siRNA delivered using aATx was quantified directly and related to siRNA activity. In addition, inhibition of ILV formation by hypertonic sucrose or wheatgerm agglutinin (WGA) was shown to inhibit the aATx-mediated cytosolic translocation of siRNA. <b>Results:</b> MCF-7 cells were used to establish siRNA intracellular distribution in relation to pharmacological activity by targeting STAT3 gene expression. After Lipofectamine-mediated transfection using 100 nM <sup>32</sup>P-labelled siRNA, 45 ± 3.2% (±SD; <i>n</i> = 3) of the cell associated siRNA was found in the cytosol. After the transfection of 100 nM <sup>32</sup>P-labelled siRNA using aATx, 77 ± 2.5% (±SD; <i>n</i> = 3) of the cell associated siRNA was found in the cytosol and resulted in a reduction in STAT3 expression of 64.04 ± 14.17% (±SD; <i>n</i> = 3) relative to an untreated control by Western analysis. Further, 25 μg/mL of WGA inhibited 75.23 ± 0.06% (±SD; <i>n</i> = 3) of the knockdown attributed to a non-WGA-treated control. Relative to the control, treatment with 200 mM sucrose resulted in a reduction of 74.58 ± 7.76% (±SD; <i>n</i> = 3) of target gene knockdown. <b>Conclusions:</b> These data indicated that the insertion of the PA pore into endosomal membrane did not weaken the endosomal limiting membrane, leading to vesicular bursting during transfection and ILVs played critical role in translocase activity.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2025-12-09
DOI
https://doi.org/10.3390/pharmaceutics17121584
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intraluminal Vesicles as Transfection Intermediaries

Marc Fivaz, Husham Abdelrahman, Benedita K. L. Feron, Simon C. W. Richardson et al.
Pharmaceutics
RNA Interference and Gene Delivery
article

Intraluminal Vesicles as Transfection Intermediaries

Marc Fivaz, Husham Abdelrahman, Benedita K. L. Feron, Simon C. W. Richardson, Timothy M. Gómez, Vineeta Tripathi, Nourhan A. M. Mahmoud, Natalie C. Youens, Andra Pintilie, Joanna J. Miest-Bray
article en

Abstract

<b>Background:</b> To address hepatotropic body distribution and toxicity, transfection systems based on protein architecture have been proposed. Attenuated anthrax toxin (aATx) has provided the backbone for a first in class transfection system that, in the wild, uses intraluminal vesicles (ILVs) as an intermediary compartment during the translocation of large molecules into the cytosol. Small interfering (si)RNA molecules non-covalently attached to a carrier (LFn-PKR) would not be predicted to be an aATx translocase (protective antigen (PA)) substrate. Previously, siRNA has been shown to be delivered to the cytosol using this system. <b>Methods:</b> Here, the localisation of <sup>32</sup>P-labelled siRNA delivered using aATx was quantified directly and related to siRNA activity. In addition, inhibition of ILV formation by hypertonic sucrose or wheatgerm agglutinin (WGA) was shown to inhibit the aATx-mediated cytosolic translocation of siRNA. <b>Results:</b> MCF-7 cells were used to establish siRNA intracellular distribution in relation to pharmacological activity by targeting STAT3 gene expression. After Lipofectamine-mediated transfection using 100 nM <sup>32</sup>P-labelled siRNA, 45 ± 3.2% (±SD; <i>n</i> = 3) of the cell associated siRNA was found in the cytosol. After the transfection of 100 nM <sup>32</sup>P-labelled siRNA using aATx, 77 ± 2.5% (±SD; <i>n</i> = 3) of the cell associated siRNA was found in the cytosol and resulted in a reduction in STAT3 expression of 64.04 ± 14.17% (±SD; <i>n</i> = 3) relative to an untreated control by Western analysis. Further, 25 μg/mL of WGA inhibited 75.23 ± 0.06% (±SD; <i>n</i> = 3) of the knockdown attributed to a non-WGA-treated control. Relative to the control, treatment with 200 mM sucrose resulted in a reduction of 74.58 ± 7.76% (±SD; <i>n</i> = 3) of target gene knockdown. <b>Conclusions:</b> These data indicated that the insertion of the PA pore into endosomal membrane did not weaken the endosomal limiting membrane, leading to vesicular bursting during transfection and ILVs played critical role in translocase activity.

PharmaceuticsVol. 17(12)
Canterbury Christ Church University (GB), Pfizer (United Kingdom) (GB), University of Greenwich (GB), October University of Modern Sciences and Arts (EG), Umeå University (SE), KU Leuven (BE)
University of Greenwich
Openalex Percentile: Top 64%
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.